IIIa deleted adenovirus as a single-cycle genome replicating vector

Virology

Volumn 462-463, Issue 1, 2014, Pages 158-165

  Crosby, Catherine M ^a   Barry, Michael A ^a,b  

^a MAYO GRADUATE SCHOOL   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Adenovirus; Amplification; Gene therapy; Replication competent; Replication defective; Single cycle; Vaccines

Indexed keywords

ADENOVIRUS VECTOR; CAPSID PROTEIN; CAPSID PROTEIN IIIA; SINGLE CYCLE ADENOVIRUS VECTOR; UNCLASSIFIED DRUG; VIRUS DNA;

ADENOVIRUS; ADENOVIRUS 6; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE EXPRESSION; GENE REPLICATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; SEROPREVALENCE; VIRAL GENE DELIVERY SYSTEM; VIRION; VIRUS GENE; VIRUS PARTICLE; VIRUS REPLICATION;

ADENOVIRUS; AMPLIFICATION; GENE THERAPY; REPLICATION-COMPETENT; REPLICATION-DEFECTIVE; SINGLE-CYCLE; VACCINES;

ADENOVIRUSES, HUMAN; ANIMALS; CAPSID PROTEINS; CELL LINE; FEMALE; GENE DELETION; GENETIC VECTORS; HUMANS; MICE; MICE, INBRED BALB C; VIRUS ASSEMBLY; VIRUS REPLICATION;

EID: 84903624706     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2014.05.030     Document Type: Article

References (28)

1. Abbink P., Lemckert A.A., Ewald B.A., Lynch D.M., Denholtz M., Smits S., Holterman L., Damen I., Vogels R., Thorner A.R., O'Brien K.L., Carville A., Mansfield K.G., Goudsmit J., Havenga M.J., Barouch D.H. Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D. J. Virol. 2007, 81:4654-4663.
2. Campos S.K., Barry M.A. Rapid construction of capsid-modified adenoviral vectors through bacteriophage lambda red recombination. Hum. Gene Ther. 2004, 15:1125-1130.
3. Campos S.K., Barry M.A. Current advances and future challenges in Adenoviral vector biology and targeting. Curr. Gene Ther. 2007, 7:189-204.
4. Cheng X., Ming X., Croyle M.A. PEGylated adenoviruses for gene delivery to the intestinal epithelium by the oral route. Pharm. Res. 2003, 20:1444-1451.
5. Couch R.B., Chanock R.M., Cate T.R., Lang D.J., Knight V., Huebner R.J. Immunization with types 4 and 7 adenovirus by selective infection of the intestinal tract. Am. Rev. Respir. Dis. 1963, 88(Suppl.):394-403.
6. Demberg T., Florese R.H., Heath M.J., Larsen K., Kalisz I., Kalyanaraman V.S., Lee E.M., Pal R., Venzon D., Grant R., Patterson L.J., Korioth-Schmitz B., Buzby A., Dombagoda D., Montefiori D.C., Letvin N.L., Cafaro A., Ensoli B., Robert-Guroff M. A replication-competent adenovirus-human immunodeficiency virus (Ad-HIV) tat and Ad-HIV env priming/Tat and envelope protein boosting regimen elicits enhanced protective efficacy against simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques. J. Virol. 2007, 81:3414-3427.
7. Demberg T., Robert-Guroff M. Mucosal immunity and protection against HIV/SIV infection: strategies and challenges for vaccine design. Int. Rev. Immunol. 2009, 28:20-48.
8. Duncan S.J., Gordon F.C., Gregory D.W., McPhie J.L., Postlethwaite R., White R., Willcox H.N. Infection of mouse liver by human adenovirus type 5. J. Gen. Virol. 1978, 40:45-61.
9. Eggerding F.A., Pierce W.C. Molecular biology of adenovirus type 2 semipermissive infections. I. Viral growth and expression of viral replicative functions during restricted adenovirus infection. Virology 1986, 148:97-113.
10. Gomez-Roman V.R., Florese R.H., Patterson L.J., Peng B., Venzon D., Aldrich K., Robert-Guroff M. A simplified method for the rapid fluorometric assessment of antibody-dependent cell-mediated cytotoxicity. J. Immunol. Methods 2006, 308:53-67.
11. Gomez-Roman V.R., Florese R.H., Peng B., Montefiori D.C., Kalyanaraman V.S., Venzon D., Srivastava I., Barnett S.W., Robert-Guroff M. An adenovirus-based HIV subtype B prime/boost vaccine regimen elicits antibodies mediating broad antibody-dependent cellular cytotoxicity against non-subtype B HIV strains. J. Acquir. Immune Defic. Syndr. 2006, 43:270-277.
12. Gomez-Roman V.R., Grimes G.J., Potti G.K., Peng B., Demberg T., Gravlin L., Treece J., Pal R., Lee E.M., Alvord W.G., Markham P.D., Robert-Guroff M. Oral delivery of replication-competent adenovirus vectors is well tolerated by SIV- and SHIV-infected rhesus macaques. Vaccine 2006, 24:5064-5072.
13. Hidajat R., Xiao P., Zhou Q., Venzon D., Summers L.E., Kalyanaraman V.S., Montefiori D.C., Robert-Guroff M. Correlation of vaccine-elicited systemic and mucosal non-neutralizing antibody activities with reduced acute viremia following intrarectal SIVmac251 challenge of rhesus macaques. J. Virol. 2009, 83(2):791-801.
14. Liu H., Jin L., Koh S.B., Atanasov I., Schein S., Wu L., Zhou Z.H. Atomic structure of human adenovirus by cryo-EM reveals interactions among protein networks. Science 2010, 329(5995):1038-1043.
15. Malkevitch N., Patterson L.J., Aldrich K., Richardson E., Alvord W.G., Robert-Guroff M. A replication competent adenovirus 5 host range mutant-simian immunodeficiency virus (SIV) recombinant priming/subunit protein boosting vaccine regimen induces broad, persistent SIV-specific cellular immunity to dominant and subdominant epitopes in Mamu-A 01 rhesus macaques. J. Immunol. 2003, 170:4281-4289.
16. Morgan C., Marthas M., Miller C., Duerr A., Cheng-Mayer C., Desrosiers R., Flores J., Haigwood N., Hu S.L., Johnson R.P., Lifson J., Montefiori D., Moore J., Robert-Guroff M., Robinson H., Self S., Corey L. The use of nonhuman primate models in HIV vaccine development. PLoS Med. 2008, 5:e173.
17. Nagayama Y., Nakao K., Mizuguchi H., Hayakawa T., Niwa M. Enhanced antitumor effect of combined replicative adenovirus and nonreplicative adenovirus expressing interleukin-12 in an immunocompetent mouse model. Gene Ther. 2003, 10:1400-1403.
18. Patterson L.J., Malkevitch N., Venzon D., Pinczewski J., Gomez-Roman V.R., Wang L., Kalyanaraman V.S., Markham P.D., Robey F.A., Robert-Guroff M. Protection against mucosal simian immunodeficiency virus SIV(mac251) challenge by using replicating adenovirus-SIV multigene vaccine priming and subunit boosting. J. Virol. 2004, 78:2212-2221.
19. Peng B., Voltan R., Cristillo A.D., Alvord W.G., Davis-Warren A., Zhou Q., Murthy K.K., Robert-Guroff M. Replicating Ad-recombinants encoding non-myristoylated rather than wild-type HIV Nef elicit enhanced cellular immunity. AIDS 2006, 20:2149-2157.
20. Peng B., Wang L.R., Gomez-Roman V.R., Davis-Warren A., Montefiori D.C., Kalyanaraman V.S., Venzon D., Zhao J., Kan E., Rowell T.J., Murthy K.K., Srivastava I., Barnett S.W., Robert-Guroff M. Replicating rather than nonreplicating adenovirus-human immunodeficiency virus recombinant vaccines are better at eliciting potent cellular immunity and priming high-titer antibodies. J. Virol. 2005, 79:10200-10209.
21. Reddy V.S., Natchiar S.K., Stewart P.L., Nemerow G.R. Crystal structure of human adenovirus at 3.5 A resolution. Science 2010, 329(5995):1071-1075.
22. Stewart P.L., Fuller S.D., Burnett R.M. Difference imaging of adenovirus: bridging the resolution gap between X-ray crystallography and electron microscopy. EMBO J. 1993, 12:2589-2599.
23. Thomas M.A., Spencer J.F., Wold W.S. Use of the Syrian hamster as an animal model for oncolytic adenovirus vectors. Methods Mol. Med. 2007, 130:169-183.
24. Weaver E.A., Nehete P.N., Buchl S.S., Senac J.S., Palmer D., Ng P., Sastry K.J., Barry M.A. Comparison of replication-competent, first generation, and helper-dependent adenoviral vaccines. PloS One 2009, 4:e5059.
25. Weaver E.A., Nehete P.N., Nehete B.P., Yang G., Buchl S.J., Hanley P.W., Palmer D., Montefiori D.C., Ferrari G., Ng P., Sastry K.J., Barry M.A. Comparison of systemic and mucosal immunization with helper-dependent adenoviruses for vaccination against mucosal challenge with SHIV. PloS One 2013, 8(7):e67574. 10.1371/journal.pone.0067574.
26. Weaver E.A., Palmer D., Ng P., Barry M.A. Characterization of species C human adenovirus serotype 6 (Ad6). Virology 2011, 412(1):19-27. 10.1016/j.virol.2010.10.041.
27. Zhao J., Lou Y., Pinczewski J., Malkevitch N., Aldrich K., Kalyanaraman V.S., Venzon D., Peng B., Patterson L.J., Edghill-Smith Y., Woodward R., Pavlakis G.N., Robert-Guroff M. Boosting of SIV-specific immune responses in rhesus macaques by repeated administration of Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinants. Vaccine 2003, 21:4022-4035.
28. Zhao J., Voltan R., Peng B., Davis-Warren A., Kalyanaraman V.S., Alvord W.G., Aldrich K., Bernasconi D., Butto S., Cafaro A., Ensoli B., Robert-Guroff M. Enhanced cellular immunity to SIV Gag following co-administration of adenoviruses encoding wild-type or mutant HIV Tat and SIV Gag. Virology 2005, 342:1-12.